Sodium–Glucose Cotransporter-2 Inhibitors Could Help Delay Renal Impairment in Patients with Type 2 Diabetes: A Real-World Clinical Setting

This study compared the renoprotective effects of sodium–glucose cotransporter-2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors in patients with type 2 diabetes mellitus (T2DM). We performed a retrospective cohort study using electronic medical records of patients with T2DM. The pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Gyunam, Choi, Byungha, Kang, Soyoung, Kim, Bomin, Chang, Min Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502124/
https://www.ncbi.nlm.nih.gov/pubmed/36142907
http://dx.doi.org/10.3390/jcm11185259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502124/
https://www.ncbi.nlm.nih.gov/pubmed/36142907
http://dx.doi.org/10.3390/jcm11185259

Ejemplares similares